Treatment of severe pregnancy‐associated hypertension with the calcium antagonist nifedipine
- 1 April 1984
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 91 (4) , 330-336
- https://doi.org/10.1111/j.1471-0528.1984.tb05918.x
Abstract
The calcium antagonist, nifedipine, was given orally to 21 women with acute episodes of severe hypertension during pregnancy or in the puerperium. A rapid and significant fall in blood pressure by an average of 26/20 mmHg was seen at 20 min after administration. The hypotensive effect was not significantly enhanced in those women already taking medication to lower the blood pressure. The principal side effects were headache and cutaneous flushing. No adverse fetal effects were detected. This is the first study of the use of this drug to control hypertension in pregnancy. The apparent efficacy of nifedipine justifies its further investigation in controlled trials.Keywords
This publication has 15 references indexed in Scilit:
- Nifedipine and beta-blockade as a cause of cardiac failure.BMJ, 1982
- Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.Circulation, 1980
- Treatment of hypertension in pregnancyKidney International, 1980
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.Circulation, 1980
- ASSESSMENT OF ANTEPARTUM CARDIOTOCOGRAMS IN HIGH‐RISK PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- A Study on the Effects of Nifedipine in Hypertensive Crises and Severe HypertensionJapanese Heart Journal, 1978
- How an acute rise in arterial pressure damages arterioles: Electron microscopic changes during angiotensin infusionCardiovascular Research, 1972